NysnoBio
Pre-clinicalNysnobio is advancing the vast power and potential of the Parkin enzyme to cure human disease with precision medicine.
Founded
2018
Focus
BiologicsRNA & Gene Therapy
About
Nysnobio is advancing the vast power and potential of the Parkin enzyme to cure human disease with precision medicine.
Funding History
2Total raised: $83M
Series A$68MRA Capital ManagementMar 15, 2022
Seed$15MRA Capital ManagementSep 15, 2020
Company Info
TypePrivate
Founded2018
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile